期刊文献+

骨髓是各种组织器官再生修复的共同干细胞库 被引量:3

下载PDF
导出
摘要 再生成年组织细胞的干细胞来源存在争论.成人组织干细胞的"跨系分化"或"可塑性"受到质疑.目前认为骨髓是储存各种原始组织干细胞的仓库:骨髓干细胞在各种细胞因子的作用下,不断通过毛细血管网进入各种组织,并在局部组织分化为原始组织干细胞;原始组织干细胞再生增殖组织特异性细胞以补充衰老损伤的细胞.由于骨髓干细胞能够自我更新,容易从骨髓及外周血获取,故对组织再生修复有着令人鼓舞的临床应用潜力.
出处 《中国分子心脏病学杂志》 CAS 2003年第3期174-181,共8页 Molecular Cardiology of China
基金 国家自然科学基金(30170374) 中国博士后科学基金(2002032128)
  • 相关文献

参考文献30

  • 1[1]van Praag H, Schinder AF, Christie BR, et al.Functional neurogenesis in the adult hippocampus.Nature, 2002; 415: 1030-1034.
  • 2[2]Laflamme MA, Myerson D, Saffitz JE, et al. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts.Circ Res, 2002; 90: 634-640.
  • 3[3]Jiang Y, Jahagirdar BN, Reinhardt RL, et al.Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002; 418: 41-49.
  • 4[4]Orlic D, Hill JM, Arai AE. Stem cells for myocardial regeneration. Circ Res, 2002; 91: 1092-1102.
  • 5[5]Lin Y, Weisdorf D, Solovey A, et al. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest, 2000; 105: 71-77.
  • 6[6]Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature,2001, 410: 701-705.
  • 7[7]Hall F, Han B, Kundu R, et al. Phenotypic differentiation of tgf-betal-responsive pluripotent premesenchymal prehematopoietic progenitor ( P4 stem ) cells from murine bone marrow. J Hematother Stem Cell Res, 2001; 10: 261-271.
  • 8[8]Krause DS. Plasticity of marrow-derived stem cells.Gene Therapy, 2002; 9: 754-758.
  • 9[9]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284: 143-147.
  • 10[10]Poulsom R, Alison MR, Forbes SJ, et al. Adult stem cell plasticity. J Pathol, 2002; 197: 441-456.

同被引文献38

  • 1[1]Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science,1999, 284:143-147
  • 2[2]Fukuda K. Use of adult marrow mesenchymal stem cells for regeneration of cardiomyocytes. Bone Marrow transplant.2003, 32 (suppl 1) : S25-27
  • 3[3]Chiu RC. Bone-marrow stem cells as a source for cell therapy. Heart Fail Rev, 2003, 8:247-251
  • 4[4]Kadiyala S, Young RG, Thiede MA, et al. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplantation, 1997, 6(2): 125-134
  • 5[5]Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg, 2002, 123:1132-1140
  • 6[6]Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest, 1999, 103:697-705
  • 7[7]Rafii S, Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration.Nature Med, 2003, 9 (6) : 702-712
  • 8[8]Quirici N, Soligo D, Caneva L, et al. Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol, 2001, 115 (1) : 186-194
  • 9[9]Gehling UM, Ergun S, Schumacher U, et al. In vitro differentiation of endothelial cells from AC 133-positive progenitor cells. Blood, 2000, 95:3106-3112
  • 10[10]Reyes M, Dudek A, Jahagirdar B, et al. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest, 2002, 109:337-346

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部